Abaxis Reports Financial Performance for the First Quarter of F... (tended to be considered in isolation or ...)

Abaxis Reports Financial Performance for the First Quarter of Fiscal 2012

Date:7/28/2011

tended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. For more information on this non-GAAP financial measure, refer to the table captioned "Operating Income Per Share" included at the end of this release. Abaxis defines operating income per share as operating income divided by the weighted average outstanding shares. Management uses this measure in comparing Abaxis' operating results with historical performance and believes it provides meaningful and comparable information to management and investors to assist in their review of Abaxis' performance relative to prior periods and its competitors.

This press release includes, and our conference call will include, statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"), including but not limited to statements related to Abaxis' cash position, financial resources and potential for future growth, market acceptance and penetration of new or planned product offerings, and future recurring revenues and results of operations. Abaxis claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," "anticipates," or words of similar import, and do not reflect historical facts. Specific forward-looking statements contained in this press release or in Abaxis' conference call may be affected by risks and uncertainties, including, but not limited to, those related to losses or system failures with respect to Abaxis' facilities or manufacturing operations, fluctuations in quarterly operating results, dependence on sole suppliers, the market acceptance of Abaxis' products and the continuing development of its products, required United States Food and Drug
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Abaxis to Report First Quarter Fiscal Year 2012 Financial Results Thursday, July 28, 2011
2. Abaxis to Present at Jefferies 2011 Global Healthcare Conference
3. Abaxis to Present at ThinkEquitys Second Annual Healthcare Conference
4. Abaxis Receives Presidential "E" Award for Exports
5. Abaxis, Inc. Awarded $650,000 from Kansas Bioscience Authority
6. Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
7. Abaxis Appoints Vernon Altman to Board of Directors
8. Abaxis to Report Fourth Quarter and Fiscal Year 2011 Financial Results Thursday, April 28, 2011
9. Abaxis, Inc. to Present at the 10th Annual Needham Healthcare Conference
10. Abaxis, Inc. to Present at RBC Capital Markets Healthcare Conference
11. Abaxis Reports Financial Performance With Record Sales for the Third Quarter of Fiscal 2011

Post Your Comments:

(Date:5/20/2013)... -- Life Technologies Corporation (NASDAQ: LIFE ... and 3500xL Dx Genetic Analyzers have been approved by ... Mexico for diagnostic use. The ... to serve the clinical end market in ... -based solutions. The Applied Biosystems™ 3500 ...

(Date:5/20/2013)... , May 20, 2013 Hyland ... healthcare industry by creating the Multi-Disciplinary Clinical Leadership ... variety of medical experts with diverse healthcare experience, ... healthcare industry to create new software solutions that ... specific needs of patients and staff. ...

(Date:5/20/2013)... May 20, 2013 Enrollment of patients with ... 2b dose-finding clinical trial of product candidate NewMet ... treatment for Type 2 diabetes. Elcelyx expects to complete ... in June. Results of the trial,s primary endpoint of ... summer, and the read-out for long-term glucose lowering and ...

Breaking Medicine Technology:Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2 Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3 Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions 2 Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2 Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3 Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4

[0] Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico [0] Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions [0] Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes

... Nov. 1, 2011 Champions Oncology, Inc. ... CSBR ) , a company engaged in the development ... development and use of oncology drugs, has appointed Gary ... Vice President and Chief Financial Officer. Joel Ackerman, the ...

... 1, 2011 Trend Micro Incorporated (TYO: 4704; TSE: ... commitment to the security of the nation,s critical healthcare ... Innovation, Safety and Security Consortium (MDISS). As ... Consortium in helping to protect public health and well-being ...

Cached Medicine Technology:Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation 2 Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation 3 Trend Micro Joins Industry Leaders in the Effort to Secure Critical IT Healthcare Infrastructure 2 Trend Micro Joins Industry Leaders in the Effort to Secure Critical IT Healthcare Infrastructure 3

Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation Trend Micro Joins Industry Leaders in the Effort to Secure Critical IT Healthcare Infrastructure

(Date:5/21/2013)... It took Willie Benitez, a heroin ... sixth time on a fifteen year sentence, six months ... to trust him enough to allow Willie to start ... “NarcoNon” Willie intended to name his “drug rehabilitation foundation,” ... and did start up that class. , Early ...

(Date:5/21/2013)... Leading New Jersey real estate agent, ... One of her favorite aspects of walkable places is ... light of the current childhood obesity epidemic that plagues ... walkable living. , A New York Academy of Sciences ... neighborhoods as a key combatant to obesity. The same ...

(Date:5/21/2013)... 2013 Dr. James C. Wittig, Chief ... the Sarcoma Division of the John Theurer Cancer Center ... been named one of the top 13 Orthopedic Oncologists ... Dr. Wittig is one of approximately 125 surgeons in ... created by surveying thought leaders in the field of ...

(Date:5/21/2013)... The Michigan Lupus Foundation will be holding a ... 11th. , Meeting Details: , Tuesday, June 11th , ... Room 5 (Lower Level), 1375 North Main Street, Lapeer, ... people with lupus and their family and friends to ... better understanding of this disease and how to fight ...

(Date:5/21/2013)... 21, 2013 Joe Vitale, a positive thinking ... adapter of the Fisker electric car. After a year and ... the car company went bankrupt, the bestselling author turned grumpy ... , "It's a gas guzzler's anthem," says Vitale, 59, who ... "Sun Will Rise." , Owning this Fisker was a ...

Breaking Medicine News(10 mins):Health News:Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 2 Health News:Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 3 Health News:Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 4 Health News:Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 5 Health News:New Jersey Realtor, Lina Panza, Advocates Walkable Neighborhoods to Combat Childhood Obesity 2 Health News:New Jersey Realtor, Lina Panza, Advocates Walkable Neighborhoods to Combat Childhood Obesity 3 Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 2 Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 3 Health News:Upset Fisker Owner Records Gas Guzzler Anthem 2

[0] Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009 [0] New Jersey Realtor, Lina Panza, Advocates Walkable Neighborhoods to Combat Childhood Obesity [0] James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists [0] Lupus Support Group Meeting in Lapeer on June 11th [0] Upset Fisker Owner Records Gas Guzzler Anthem

... someday help control anxiety, experts say, , , FRIDAY, May 15 ... anxiety isn,t something associated with heights, a job interview or ... state of worry and tension that affects twice as many ... slowly eroding their quality of life. , But a new ...

... ORLANDO A pill used for nerve pain offers women ... 45th Annual Meeting of the American Society of Clinical ... hot flash severity and frequency about 20 percent more than ... the same benefit as gabapentin, an older, related drug, as ...

... in GI and Endoscopy Nursing at SGNA 36th Annual ... Nurses and Associates, Inc. (SGNA) is proud to honor ... awards that recognize their dedication to the field and ... distinguished awards represent the best in GI and endoscopy ...

... Palatin Technologies, Inc. (NYSE Amex: PTN ) announced ... Palatin reported net income of $0.1 million, or $0.00 per basic ... to a net loss of $5.1 million, or $0.06 per basic ... revenues in the quarter ended March 31, 2009 were $5.2 million, ...

... 15 /PRNewswire-Asia-FirstCall/ -- Shengtai,Pharmaceutical, Inc. (OTC Bulletin Board: ... distributor of high-quality, pharmaceutical grade,glucose products in China, ... of fiscal 2009 ended March 31, 2009. , ... has impacted our operations thus far in,fiscal year ...

... Dr. Bruno E. Gerber is recognized in ... is a Consultant Orthopedic Surgeon with a special ... of the lower limbs. He also is employed ... development project regarding innovative orthopedic laser treatment.Dr. Gerber ...

Fear Response May Stem From Protein in Brain Mayo Clinic researchers say agent provides treatment option for women with hot flashes SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results Continental Who's Who Executive Press Release: Dr. Bruno E. Gerber - Medical Professional

... The TOPCON OM-4 Ophthalmometer ... compactly designed and easy ... providing precise objective measurements ... of curvature plus accurate ...

... Based on the latest digital chip ... FA/Color System from Topcon features 3,072 x ... range for each color channel! The system ... also features real-time image acquisition, which facilitates ...

... Set offers a maximum selection ... corrected curve additive design that ... spacing between combined lenses. This ... be read directly from the ...

... power table has everything that you need ... new AIT-15 offers 20 mm of additional ... and locking castors to secure the table. ... for most any application. Use a double ...

Medicine Products:

Topcon OM-4 Ophthalmometer Topcon IMAGEnet 2000 FA/Color System with 3,072 x 2,048 pixels Topcon TLS-FD trial lens set AIT-15 instrument table